Cambridge Investment Research Advisors, Inc. Omeros Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 15,443 shares of OMER stock, worth $159,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,443
Previous 14,243
8.43%
Holding current value
$159,217
Previous $58,000
5.17%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding OMER
# of Institutions
120Shares Held
25.6MCall Options Held
228KPut Options Held
630K-
Ingalls & Snyder LLC New York, NY4.54MShares$46.8 Million0.7% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$42.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$33.6 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.9MShares$19.6 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.61MShares$16.6 Million0.01% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $647M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...